Posted in:Legal The Federal Circuit Affirms District Court Finding that Sandoz Does Not Infringe Amgen’s Protein Purification Patent By Andrew Storaska June 20, 2019 Comments are off In a recent precedential opinion, the Federal Circuit rejected arguments by Amgen that a single step purification process used by Sandoz... Read more Tagged with: aBLA, Amgen, Amgen v. Sandoz, doctrine of equivalents, FDA, Featured, Federal Circuit, Sandoz http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus